Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment

Clinically significant depression is present in one of every four people with type 2 diabetes mellitus (T2DM). Depression increases the risk of the development of T2DM and the subsequent risks of hyperglycemia, insulin resistance, and micro- and macrovascular complications. Conversely, a diagnosis o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs (New York, N.Y.) N.Y.), 2015-04, Vol.75 (6), p.577-587
Hauptverfasser:	Semenkovich, Katherine, Brown, Miriam E., Svrakic, Dragan M., Lustman, Patrick J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressants Antidepressive Agents - therapeutic use Cognition & reasoning Cognitive Therapy Comorbidity Cross-sectional studies Depression - drug therapy Depression - epidemiology Depression - prevention & control Depressive Disorder - drug therapy Depressive Disorder - epidemiology Depressive Disorder - prevention & control Diabetes Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - prevention & control Disability Health care Humans Hyperglycemia Hypoglycemic Agents - therapeutic use Insulin Internal Medicine Medicine Medicine & Public Health Mental depression Mental disorders Pharmacology/Toxicology Pharmacotherapy Review Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!